Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Smith & Nephew plc (SNN) – Smith & Nephew plc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Smith & Nephew (SNN) trades at $31.73, down 1.26% today, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported strong 2025 results with revenue reaching $6.2B and net income jumping to $625M, beating Q4 EPS expectations. Recent product launches in wound care and orthopedic robotics demonstrate ongoing innovation, while the completion of the Integrity Orthopaedics acquisition strengthens its sports medicine portfolio.
The outlook remains cautiously optimistic with improving profitability and strategic expansions, though recent earnings misses and a high analyst hold rating suggest near-term headwinds. Key risks include execution challenges in the orthopedics segment and competitive pressures, while institutional selling activity warrants monitoring for sustained momentum.
Read full analysis

Key Stats

  • Market Cap
    $13.59B
  • Sector
    Health
  • 3M Drawdown
    -14.39%
  • Enterprise Value
    $16.36B
  • Dividend Yield
    2.4%
  • Typical Hold Time
    116 days
$32.6
52W Low: $24.97
08 Apr 2025
52W High: $38.7
09 Sep 2025

Smith & Nephew plc (SNN) is currently valued at a market capitalization of $13.59B, with an enterprise value of $16.36B. Over the past 52 weeks, Smith & Nephew plc has traded between a low of $24.97 and a high of $38.7, highlighting its annual price range. Over the past three months, Smith & Nephew plc has recorded a drawdown of -14.39%, reflecting recent price volatility. Smith & Nephew plc offers a dividend yield of 2.4%, with the most recent dividend of $0.48 paid on 27 Mar 26. On average, investors hold Smith & Nephew plc for approximately 116 days, indicating typical investor behavior on the platform.

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.


Technical Indicators
|
|
|
Overall Summary
Bearish (8)Neutral (12)Bullish (7)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $13.59B
  • Sector
    Health
  • 3M Drawdown
    -14.39%
  • Enterprise Value
    $16.36B
  • Dividend Yield
    2.4%
  • Typical Hold Time
    116 days
$32.6
52W Low: $24.97
08 Apr 2025
52W High: $38.7
09 Sep 2025

Smith & Nephew plc (SNN) is currently valued at a market capitalization of $13.59B, with an enterprise value of $16.36B. Over the past 52 weeks, Smith & Nephew plc has traded between a low of $24.97 and a high of $38.7, highlighting its annual price range. Over the past three months, Smith & Nephew plc has recorded a drawdown of -14.39%, reflecting recent price volatility. Smith & Nephew plc offers a dividend yield of 2.4%, with the most recent dividend of $0.48 paid on 27 Mar 26. On average, investors hold Smith & Nephew plc for approximately 116 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!